✦ LIBER ✦

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

✍ Scribed by Oliver F Bathe; Scott Ernst; Francis R Sutherland; Elijah Dixon; Charles Butts; David Bigam; David Holland; Geoffrey A Porter; Jennifer Koppel; Scot Dowden

Book ID: 115011567
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 327 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-156

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of neoadjuvant 5-FU + leu

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

✍ Oliver F Bathe; Scot Dowden; Francis Sutherland; Elijah Dixon; Charles Butts; Da 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 294 KB

Phase II Study of UFT with Leucovorin Pl

Phase II Study of UFT with Leucovorin Plus Hepatic Arterial Infusion with Irinotecan, 5-Fluorouracil and Leucovorin for Non-Resectable Liver Metastases of Colorectal Cancer

✍ Idelevich, Efraim; Greif, Franklin; Mavor, Eli; Miller, Rafael; Kashtan, Hanoch; 📂 Article 📅 2008 🏛 S. Karger AG 🌐 English ⚖ 189 KB

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

Phase I/II study of irinotecan, UFT and

Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases

✍ Tatsuro Yamaguchi; Hiroshi Matsumoto; Michiya Yasutome; Takeo Mori; Keiichi Taka 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 310 KB

Folinic acid (FA) and 5-fluorouracil (FU

Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial

✍ E. Maiello; F. Giuliani; V. Gebbia; S. Cigolari; S. Fortunato; G. Paoletti; N. B 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Capecitabine plus Irinotecan (XELIRI reg

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

✍ Erik Skof; Martina Rebersek; Zvezdana Hlebanja; Janja Ocvirk 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 288 KB